Read our Report and Recommendations
Hepatitis C virus (HCV) is the most common chronic blood-borne pathogen in the US and a leading cause of complications from chronic liver disease. In 2018, an estimated 59,100 Washingtonians were living with HCV, prompting Governor Inslee to issue Directive of the Governor 18-13: “Eliminating Hepatitis C in Washington in 2030 through combined public health efforts and a new medication purchasing approach.”
You can scroll down to the bottom of this page to view data from the Washington State Department of Health on Hepatitis C incidents and prevalence in Washington. Currently, there is no dashboard on screening rates or treatment for Hepatitis C.
Past Meeting Materials
Workgroup Members
| Name | Title | Organization |
| Abha Puri, MPH | Program Manager | Community Health Plan of Washington |
| Emalie Huriaux, MPH | STD, Adult Hepatitis, and Syringe Service Program (SSP) Manager | WA Department of Health |
| John Scott, MD, MSc | Professor, Department of Medicine Medical Director, Telehealth Associate Medical Director, Liver Clinic |
University of Washington |
| Jon Stockton, MHA | Adult Viral Hepatitis Coordinator | WA Department of Health |
| Judith Tsui, MD, MPH | Associate Professor, Department of Medicine Director, UW Medical Student Addiction Research Program |
University of Washington |
| Melda Velasquez | Service Line Director | Kadlec Regional Medical Center |
| Omar Daoud, PharmD | Director of Pharmacy | Community Health Plan of Washington |
| Patrick Judkins | Education and Outreach Specialist, Disease Control and Prevention | Thurston County Health Department |
| Ryan Pistoresi, PharmD, MS | Assistant Chief Pharmacy Officer | Washington State Health Care Authority |
| Wendy Wong, BSc | Ambulatory Clinical Pharmacist | Providence Health and Services |
| Vania Rudolph, MD, MPH | Addiction Medicine Specialist | Swedish Health Centers |
| Yumi Ando, MD | Gastroenterologist | Kaiser Permanente |